Literature DB >> 12075344

Angiotensin-converting enzyme 2 is an essential regulator of heart function.

Michael A Crackower1, Renu Sarao, Gavin Y Oudit, Chana Yagil, Ivona Kozieradzki, Sam E Scanga, Antonio J Oliveira-dos-Santos, Joan da Costa, Liyong Zhang, York Pei, James Scholey, Carlos M Ferrario, Armen S Manoukian, Mark C Chappell, Peter H Backx, Yoram Yagil, Josef M Penninger.   

Abstract

Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075344     DOI: 10.1038/nature00786

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  606 in total

Review 1.  Role of ACE2 in diastolic and systolic heart failure.

Authors:  Wang Wang; Sreedhar Bodiga; Subhash K Das; Jennifer Lo; Vaibhav Patel; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 2.  Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology.

Authors:  Carlos M Ferrario
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

3.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

4.  ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Srinivas Sriramula; Jeffrey P Cardinale; Eric Lazartigues; Joseph Francis
Journal:  Cardiovasc Res       Date:  2011-09-27       Impact factor: 10.787

5.  ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Authors:  Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-04       Impact factor: 4.310

6.  Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.

Authors:  Thomas Simon O'Hagan; Whitney Wharton; Patrick Gavin Kehoe
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

7.  Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.

Authors:  Taiji Matsusaka; Fumio Niimura; Ira Pastan; Ayumi Shintani; Akira Nishiyama; Iekuni Ichikawa
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

8.  The High Blood Pressure-Malaria Protection Hypothesis.

Authors:  Julio Gallego-Delgado; Thomas Walther; Ana Rodriguez
Journal:  Circ Res       Date:  2016-09-22       Impact factor: 17.367

Review 9.  Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19.

Authors:  Ziyin Huang; Yufeng Jiang; Jingjing Chen; Yafeng Zhou
Journal:  Cardiol J       Date:  2020-04-14       Impact factor: 2.737

Review 10.  Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018).

Authors:  Sarfaraz Ahmad; Carlos M Ferrario
Journal:  Expert Opin Ther Pat       Date:  2018-10-10       Impact factor: 6.674

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.